Citation 80982

TAKASAKI,M: YAMAUCHI,I: HARUNA,M: KONOSHIMA,T:. (1998). NEW GLYCOSIDES FROM AJUGA DECUMBENS.. 61(9)

Citation Details

Title	NEW GLYCOSIDES FROM AJUGA DECUMBENS.
Authors	TAKASAKI,M: YAMAUCHI,I: HARUNA,M: KONOSHIMA,T:
Year	1998
Volume	61
Issue	9

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Ajuga decumbens (LAMIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MARTYNOSIDE,GALACTOSYL:	None
2	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARTYNOSIDE,GALACTOSYL:	ACTIVE
3	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARTYNOSIDE,GALACTOSYL:	WEAK ACTIVITY
4	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARTYNOSIDE,GALACTOSYL:	WEAK ACTIVITY
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	AJUGASIDE A	None
6	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AJUGASIDE A	ACTIVE
7	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AJUGASIDE A	WEAK ACTIVITY
8	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AJUGASIDE A	WEAK ACTIVITY
9	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	MARTYNOSIDE A	None
10	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARTYNOSIDE A	ACTIVE
11	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARTYNOSIDE A	WEAK ACTIVITY
12	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARTYNOSIDE A	WEAK ACTIVITY
13	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	DARENDOSIDE A	None
14	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DARENDOSIDE A	WEAK ACTIVITY
15	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DARENDOSIDE A	WEAK ACTIVITY
16	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DARENDOSIDE A	INACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	REPTOSIDE	None
18	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REPTOSIDE	ACTIVE
19	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REPTOSIDE	WEAK ACTIVITY
20	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REPTOSIDE	INACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HARPAGIDE,8-O-ACETYL:	None
22	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HARPAGIDE,8-O-ACETYL:	ACTIVE
23	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HARPAGIDE,8-O-ACETYL:	ACTIVE
24	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HARPAGIDE,8-O-ACETYL:	WEAK ACTIVITY
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HARPAGIDE	None
26	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HARPAGIDE	ACTIVE
27	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HARPAGIDE	WEAK ACTIVITY
28	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HARPAGIDE	WEAK ACTIVITY

Citation 80982

Citation Details

Summary

Organisms and Their Experiments (1)

Ajuga decumbens (LAMIACEAE)

Show SPARQL Queries (1)

Query 1